600200.SS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 15:00):

JiangSu WuZhong Pharmaceutical Development Co., Ltd., together with its subsidiaries, engages in pharmaceutical, real estate, and chemical businesses in China...

Stats
今日成交量	46.04M
平均成交量	52.91M
市值	7.43B
EPS	CNY0 ( 2023-10-30 )
下一个收益日期	( CNY0 ) 2024-05-16
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-81.15
ATR14	CNY0.0160 (0.15%)

音量相关性

長: 0.23 (neutral)

短: 0.03 (neutral)

Signal:(62.036) Neutral

JiangSu WuZhong 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

JiangSu WuZhong 相关性 - 货币/商品

0.33
( neutral )

0.18
( neutral )

0.00
( neutral )

0.11
( neutral )

0.00
( neutral )

0.38
( neutral )

JiangSu WuZhong 财务报表

Annual	2023
营收:	CNY2.23B
毛利润:	CNY506.68M (22.76 %)
EPS:	CNY-0.100

FY	2023
营收:	CNY2.23B
毛利润:	CNY506.68M (22.76 %)
EPS:	CNY-0.100

FY	2022
营收:	CNY2.03B
毛利润:	CNY579.66M (28.61 %)
EPS:	CNY-0.110

FY	2021
营收:	CNY1.78B
毛利润:	CNY511.92M (28.83 %)
EPS:	CNY0.0300

Financial Reports:

No articles found.

JiangSu WuZhong

JiangSu WuZhong Pharmaceutical Development Co., Ltd., together with its subsidiaries, engages in pharmaceutical, real estate, and chemical businesses in China. It develops, produces, and sells anti-infective, digestive system, cardiovascular, cerebrovascular, antiviral, vitamin, and hemostatic drugs; and immunomodulations, including biopharmaceuticals, chemical drugs, and modern Chinese medicines. The company offers its products in various forms, such as infusion solutions, water and powder injections, capsules, granules, tablets, emulsions, and oral liquids. It also engages in the research, development, production, and sale of dyes and dye intermediates; and the fields of commercial housing and affordable housing development. The company was founded in 1994 and is based in Suzhou, China.